ALKEM LABORATORIES
Back to Income Statement
|
ALKEM LABORATORIES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹2,165 Cr | ₹1,796 Cr | ₹984 Cr | ₹1,646 Cr | ₹1,585 Cr |
What is the latest Consolidated Net Profit of ALKEM LABORATORIES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹2,165 Cr |
| Mar2025 | ₹1,796 Cr |
| Mar2024 | ₹984 Cr |
| Mar2023 | ₹1,646 Cr |
| Mar2022 | ₹1,585 Cr |
How is Consolidated Net Profit of ALKEM LABORATORIES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,165 Cr | 20.59 | |
| Mar2025 | ₹1,796 Cr | 82.47 | |
| Mar2024 | ₹984 Cr | -40.19 | |
| Mar2023 | ₹1,646 Cr | 3.82 | |
| Mar2022 | ₹1,585 Cr | - | |
Compare Consolidated Net Profit of peers of ALKEM LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALKEM LABORATORIES | ₹61,594.0 Cr | -0.1% | 0.1% | -6.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹424,202.0 Cr | 0.5% | -2.9% | 5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹264,141.0 Cr | 5% | 7.2% | 49.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹174,402.0 Cr | -0.5% | -4.5% | 28.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,868.0 Cr | 2.7% | 8.4% | 5.1% | Stock Analytics | |
| CIPLA | ₹111,650.0 Cr | 2.4% | 2.4% | -12.9% | Stock Analytics | |
ALKEM LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALKEM LABORATORIES | -0.1% |
0.1% |
-6.3% |
| SENSEX | 2.8% |
4.4% |
-10.1% |
You may also like the below Video Courses